Medical use of artemisinin compounds and gephyrin agonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9999621
SERIAL NO

15303170

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention refers to BTBD9 binders and gephyrin binders for medical use and in particular an artemisinin compound of general formula I for use in the treatment of a diabetes patient, as well as a method of identifying suitable lead candidates.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CEMM - FORSCHUNGSZENTRUM FUR MOLEKULARE MEDIZIN GMBH1090 WIEN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kubicek, Stefan Vienna, AT 19 90
Li, Jin Vienna, AT 561 11650

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 19, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 19, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00